A meta-analysis of cognitive deficits in first-episode major depressive disorder

RSC Lee, DF Hermens, MA Porter… - Journal of affective …, 2012 - Elsevier
BACKGROUND: Recurrent-episode Major Depressive Disorder (MDD) is associated with a
number of neuropsychological deficits. To date, less is known about whether these are …

Major depressive disorder

C Otte, SM Gold, BW Penninx, CM Pariante… - Nature reviews Disease …, 2016 - nature.com
Major depressive disorder (MDD) is a debilitating disease that is characterized by
depressed mood, diminished interests, impaired cognitive function and vegetative …

Saffron in the treatment of depression, anxiety and other mental disorders: Current evidence and potential mechanisms of action

M Shafiee, S Arekhi, A Omranzadeh… - Journal of Affective …, 2018 - Elsevier
Background Depression and anxiety are two common mental health problems with high
economic and social costs. Currently, a number of treatments are available for patients with …

Nutrition and depression: implications for improving mental health among childbearing-aged women

LM Bodnar, KL Wisner - Biological psychiatry, 2005 - Elsevier
Adequate nutrition is needed for countless aspects of brain functioning. Poor diet quality,
ubiquitous in the United States, may be a modifiable risk factor for depression. The objective …

Pharmacological effects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorder

A Mørk, A Pehrson, LT Brennum, SM Nielsen… - … of Pharmacology and …, 2012 - ASPET
1-[2-(2, 4-Dimethylphenyl-sulfanyl)-phenyl]-piperazine (Lu AA21004) is a human (h)
serotonin (5-HT) 3A receptor antagonist (Ki= 3.7 nM), h5-HT7 receptor antagonist (K i= 19 …

Leptin: a potential novel antidepressant

XY Lu, CS Kim, A Frazer… - Proceedings of the …, 2006 - National Acad Sciences
Leptin, a hormone secreted from adipose tissue, was originally discovered to regulate body
weight. The localization of the leptin receptor in limbic structures suggests a potential role for …

Sexual dysfunction in depression and anxiety: conceptualizing sexual dysfunction as part of an internalizing dimension

SM Laurent, AD Simons - Clinical psychology review, 2009 - Elsevier
Sexual dysfunction is often implicated in depression and anxiety disorders, but the current
nosology of sexual dysfunction, depression, and anxiety (ie, DSM-IV) does not adequately …

[HTML][HTML] Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment

FJ McMahon, S Buervenich, D Charney… - The American Journal of …, 2006 - cell.com
Depressive disorders account for a large and increasing global burden of disease. Although
the condition of many patients improves with medication, only a minority experience full …

Hypericum perforatum in the treatment of psychiatric and neurodegenerative disorders: Current evidence and potential mechanisms of action

N Zirak, M Shafiee, G Soltani, M Mirzaei… - Journal of cellular …, 2019 - Wiley Online Library
Background Psychiatric disorders are substantially associated with reduced quality of life
and increased mortality. Depression and anxiety are two of the most common psychiatric …

Pathophysiology of negative symptom dimensions of schizophrenia–current developments and implications for treatment

I Bègue, S Kaiser, M Kirschner - Neuroscience & Biobehavioral Reviews, 2020 - Elsevier
Negative symptoms of schizophrenia comprise a group of severe symptoms contributing to
high disease burden and poor long-term prognosis. Conceptual work has shown that these …